other material
confidence high
sentiment neutral
materiality 0.50
Context Therapeutics stockholders approve doubling authorized shares to 200M
Context Therapeutics Inc.
- Stockholders voted 42,389,461 for, 790,853 against, 71,655 abstain to increase authorized common shares to 200,000,000.
- Authorization increased from 100,000,000 to 200,000,000 shares of common stock.
- Special Meeting held September 17, 2024; quorum of 43,251,969 shares (57.67%) present.
- Proposal also included approval of adjournments if needed, passed with 42,447,035 votes for.